Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Caixia Wang, Li Su, Qiuling Mu, Xueyan Gu, Xuejun Guo & Xuxia Wang. (2021) Cost-effectiveness analysis of domestic 13-valent pneumococcal conjugate vaccine for children under 5 years of age in mainland China. Human Vaccines & Immunotherapeutics 17:7, pages 2241-2248.
Read now
Read now
Johnna Perdrizet, Carlos Felipe S. Santana, Thais Senna, Rodrigo Fernandes Alexandre, Rodrigo Sini de Almeida, Julia Spinardi & Matt Wasserman. (2021) Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants. Human Vaccines & Immunotherapeutics 17:4, pages 1162-1172.
Read now
Read now
Nguyen Quynh Hoa, Pham Thi Lan, Ho D. Phuc, Nguyen Thi Kim Chuc & Cecilia Stalsby Lundborg. (2017) Antibiotic prescribing and dispensing for acute respiratory infections in children: effectiveness of a multi-faceted intervention for health-care providers in Vietnam. Global Health Action 10:1.
Read now
Read now
Articles from other publishers (31)
Xu Huang, Hua Tan, Feng Lu, Genglin Guo, Mingxiao Han, Tongbo Cai & Haifang Zhang. (2023)
Molecular characterization of invasive
Streptococcus pneumoniae
clinical isolates from a tertiary children’s hospital in eastern China
. Microbiology Spectrum 11:5.
Crossref
Crossref
Kimberley Rose Dean, Archana Koirala & Harsha Samarasekara. (2023) A case report of disseminated Streptococcus pneumoniae infection complicated by infective endocarditis, septic arthritis and epidural abscess in an immunocompetent patient. Access Microbiology 5:7.
Crossref
Crossref
Xinren Che, Qinghua Chen, Yan Liu, Lintao Gu, Zhaojun Lu, Wenwen Gu, Jun Wang, Wei Jiang, Jian Du, Xiaoping Zhang, Yuyang Xu, Xuechao Zhang, Jing Wang, Qixin Xie & Yingying Yang. (2023) Analysis of 13-valent pneumococcal polysaccharide conjugate vaccine among children born in Hangzhou from 2017 to 2021. Frontiers in Public Health 11.
Crossref
Crossref
Jia Guo, Haijun Zhang, Haonan Zhang, Xiaozhen Lai, Jiahao Wang, Huangyufei Feng & Hai Fang. (2023) Cost-effectiveness of pneumococcal vaccines among adults aged 65 years and older in China: A comparative study. Vaccine 41:3, pages 716-723.
Crossref
Crossref
Rafael Bolaños-Díaz, Greta Miño-León & Eduardo Zea. (2022) Cost-effectiveness of the 13-valent pneumococcal conjugate vaccine compared to the 10-valent vaccine in children: predictive analysis in the Ecuadorian context. Journal of Pharmaceutical Health Services Research 13:4, pages 341-350.
Crossref
Crossref
A. A. Kurkova, A. A. Muraviov & R. S. Kozlov. (2022) The current status of antimicrobial resistance of <i>Streptococcus pneumoniae</i> and specific vaccine prevention of pneumococcal infection. PULMONOLOGIYA 33:4, pages 534-541.
Crossref
Crossref
Adriana Aurelia Chiș, Luca Liviu Rus, Claudiu Morgovan, Anca Maria Arseniu, Adina Frum, Andreea Loredana Vonica-Țincu, Felicia Gabriela Gligor, Maria Lucia Mureșan & Carmen Maximiliana Dobrea. (2022) Microbial Resistance to Antibiotics and Effective Antibiotherapy. Biomedicines 10:5, pages 1121.
Crossref
Crossref
Chiara Scelfo, Francesco Menzella, Matteo Fontana, Giulia Ghidoni, Carla Galeone & Nicola Cosimo Facciolongo. (2021) Pneumonia and Invasive Pneumococcal Diseases: The Role of Pneumococcal Conjugate Vaccine in the Era of Multi-Drug Resistance. Vaccines 9:5, pages 420.
Crossref
Crossref
Rendani I. Manenzhe, Felix S. Dube, Meredith Wright, Katie Lennard, Stephanie Mounaud, Stephanie W. Lo, Heather J. Zar, William C. Nierman, Mark P. Nicol & Clinton Moodley. (2020) Characterization of Pneumococcal Colonization Dynamics and Antimicrobial Resistance Using Shotgun Metagenomic Sequencing in Intensively Sampled South African Infants. Frontiers in Public Health 8.
Crossref
Crossref
Sarah Pugh, Matt Wasserman, Margaret Moffatt, Susana Marques, Juan Manuel Reyes, Victor A. Prieto, Davy Reijnders, Mark H. Rozenbaum, Juha Laine, Heidi Åhman & Raymond Farkouh. (2020) Estimating the Impact of Switching from a Lower to Higher Valent Pneumococcal Conjugate Vaccine in Colombia, Finland, and The Netherlands: A Cost-Effectiveness Analysis. Infectious Diseases and Therapy 9:2, pages 305-324.
Crossref
Crossref
Mariya Malcheva, Iva Philipova, Ivan Simeonovski, Viktoriya Levterova, Nadyia Brankova & Todor Kantardjiev. (2020) ANTIMICROBIAL SUSCEPTIBILITY OF S. PNEUMONIAE STRAINS ISOLATED FROM CHILDREN WITH NASOPHARYNGEAL CARRIAGE. PROBLEMS of Infectious and Parasitic Diseases 48:1, pages 15-20.
Crossref
Crossref
Srigouri Huddar, Chul Min Park, Hyung Jun Kim, Soojin Jang & Sunkyung Lee. (2020) Discovery of 4-hydroxy-2-oxo-1,2-dihydroquinolines as potential inhibitors of Streptococcus pneumoniae, including drug-resistant strains. Bioorganic & Medicinal Chemistry Letters 30:9, pages 127071.
Crossref
Crossref
Filippo Ansaldi, Sarah Pugh, Daniela Amicizia, Roberto Di Virgilio, Cecilia Trucchi, Andrea Orsi, Alessandro Zollo & Giancarlo Icardi. (2020) Estimating the Clinical and Economic Impact of Switching from the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) to the 10-Valent Pneumococcal Conjugate Vaccine (PCV10) in Italy. Pathogens 9:2, pages 76.
Crossref
Crossref
Xu Han, Niurka Molina Águila, Haiyang Yu, C. Nivaldo Linares Pérez & C. María Eugenia Toledo Romaní. (2020) Serotypic distribution and antimicrobial resistance of Streptococcus pneumoniae in Chinese children under 5 years after the introduction of the 13-valent conjugate pneumococcal vaccine: protocol for a scoping review. F1000Research 9, pages 221.
Crossref
Crossref
Michele Wilson, Matt Wasserman, Taj Jadavi, Maarten Postma, Marie-Claude Breton, Francois Peloquin, Stephanie Earnshaw, Cheryl McDade, Heather Sings & Raymond Farkouh. (2018) Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada. Infectious Diseases and Therapy 7:3, pages 353-371.
Crossref
Crossref
Jyotsana Singh, Suba Sundaresan, Anand Manoharan & Anita Shet. (2017) Serotype distribution and antimicrobial susceptibility pattern in children ≤ 5 years with invasive pneumococcal disease in India – A systematic review. Vaccine 35:35, pages 4501-4509.
Crossref
Crossref
Hyung Jun KimNamyoul KimDavid ShumSrigouri HuddarChul Min ParkSoojin Jang. (2017)
Identification of Antipneumococcal Molecules Effective Against Different
Streptococcus pneumoniae
Serotypes Using a Resazurin-Based High-Throughput Screen
. ASSAY and Drug Development Technologies 15:5, pages 198-209.
Crossref
Crossref
Serena Tricarico, Hannah C. McNeil, Michael G. Head, David W. Cleary & Stuart C. Clarke. (2017) Informing pneumococcal conjugate vaccine policy in middle-income countries: The case of Malaysia. Vaccine 35:18, pages 2288-2290.
Crossref
Crossref
Masha Somi & Brendan Murphy. (2017) Maintaining momentum on immunisation in Australia. Microbiology Australia 38:4, pages 159.
Crossref
Crossref
Indrė Stacevičienė, Sigita Petraitienė, Daiva Vaičiūnienė, Tomas Alasevičius, Jūratė Kirslienė & Vytautas Usonis. (2016) Antibiotic resistance of Streptococcus pneumoniae, isolated from nasopharynx of preschool children with acute respiratory tract infection in Lithuania. BMC Infectious Diseases 16:1.
Crossref
Crossref
Ann Lindstrand, Ilias Galanis, Jessica Darenberg, Eva Morfeldt, Pontus Naucler, Margareta Blennow, Tobias Alfvén, Birgitta Henriques-Normark & Åke Örtqvist. (2016) Unaltered pneumococcal carriage prevalence due to expansion of non-vaccine types of low invasive potential 8 years after vaccine introduction in Stockholm, Sweden. Vaccine 34:38, pages 4565-4571.
Crossref
Crossref
Mark R. Alderson. (2016) Status of research and development of pediatric vaccines for Streptococcus pneumoniae. Vaccine 34:26, pages 2959-2961.
Crossref
Crossref
Jin Yang Baek, Cheol-In Kang, So Hyun Kim, Kwan Soo Ko, Doo Ryeon Chung, Kyong Ran Peck, Po-Ren Hsueh, Visanu Thamlikitkul, Thomas Man-kit So, Nam Yong Lee & Jae-Hoon Song. (2016) In vitro activity of Tedizolid phosphate against multidrug-resistant Streptococcus pneumoniae isolates from Asian countries. Diagnostic Microbiology and Infectious Disease 85:2, pages 218-220.
Crossref
Crossref
Sigita Petraitiene, Tomas Alasevicius, Indre Staceviciene, Daiva Vaiciuniene, Tomas Kacergius & Vytautas Usonis. (2015) The influence of Streptococcus pneumoniae nasopharyngeal colonization on the clinical outcome of the respiratory tract infections in preschool children. BMC Infectious Diseases 15:1.
Crossref
Crossref
A. Kwetkat, S. Hagel, C. Forstner & M.W. Pletz. (2015) Pneumonieprävention durch PneumokokkenimpfungPneumococcal vaccination for prevention of pneumonia. Zeitschrift für Gerontologie und Geriatrie 48:7, pages 614-618.
Crossref
Crossref
Marjorie E. Doyle. (2015) Multidrug-Resistant Pathogens in the Food Supply. Foodborne Pathogens and Disease 12:4, pages 261-279.
Crossref
Crossref
Mao-Che Wang, Ying-Piao Wang, Chia-Huei Chu, Tzong-Yang Tu, An-Suey Shiao & Pesus Chou. (2015) Impact of Pneumococcal Conjugate Vaccine on Pediatric Tympanostomy Tube Insertion in Partial Immunized Population. The Scientific World Journal 2015, pages 1-8.
Crossref
Crossref
C. Forstner & M.W. Pletz. (2014) PneumokokkenimpfungPneumococcal vaccination. Der Pneumologe 11:6, pages 506-515.
Crossref
Crossref
M. Imöhl, R. R. Reinert, P. M. Tulkens & M. van der Linden. (2014) Penicillin susceptibility breakpoints for Streptococcus pneumoniae and their effect on susceptibility categorisation in Germany (1997–2013). European Journal of Clinical Microbiology & Infectious Diseases 33:11, pages 2035-2040.
Crossref
Crossref
C Gudiol, C Garcia-Vidal, M Arnan, I Sánchez-Ortega, B Patiño, R Duarte & J Carratalà. (2014) Etiology, clinical features and outcomes of pre-engraftment and post-engraftment bloodstream infection in hematopoietic SCT recipients. Bone Marrow Transplantation 49:6, pages 824-830.
Crossref
Crossref
Sharmila J. Talekar, Sopio Chochua, Katie Nelson, Keith P. Klugman, Cassandra L. Quave & Jorge E. Vidal. (2014) 220D-F2 from Rubus ulmifolius Kills Streptococcus pneumoniae Planktonic Cells and Pneumococcal Biofilms. PLoS ONE 9:5, pages e97314.
Crossref
Crossref